首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action
【24h】

Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action

机译:Calix的合成[4]具有抗氧化剂,乙酰胆碱酯酶,丁二醇酸酶,酪氨酸酶和碳酸酐酶抑制作用的唑克罗敦取代磺胺

获取原文
       

摘要

A series of novel calix[4]azacrown substituted sulphonamide Schiff bases was synthesised by the reaction of calix[4]azacrown aldehydes with different substituted primary and secondary sulphonamides. The obtained novel compounds were investigated as inhibitors of six human (h) isoforms of carbonic anhydrases (CA, EC 4.2.1.1). Their antioxidant profile was assayed by various bioanalytical methods. The calix[4]azacrown substituted sulphonamide Schiff bases were also investigated as inhibitors of acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and tyrosinase enzymes, associated with several diseases such as Alzheimer, Parkinson, and pigmentation disorders. The new sulphonamides showed low to moderate inhibition against hCAs, AChE, BChE, and tyrosinase enzymes. However, some of them possessed relevant antioxidant activity, comparable with standard antioxidants used in the study.
机译:通过CALIX [4]阿尔德敦醛与不同取代的初级和仲磺酰胺的反应合成了一系列新的CALIX [4]亚辛克罗敦取代的磺胺席氏席基。研究了所得新化合物作为碳酸酐酶(CA,EC 4.2.1.1)的六种人(H)同种型的抑制剂。通过各种生物分析方法测定它们的抗氧化曲线。 Calix [4]亚辛罗敦取代的磺胺酰胺Schiff基碱还被研究为乙酰胆碱酯酶(ACHE),丁二醇酸酶(BCHE)和酪氨酸酶的抑制剂,与诸如阿尔茨海默,帕金森和色素沉着疾病如诸如阿尔茨海默氏症等疾病的抑制剂。新的磺酰胺显示出低于HCA,ACHE,BCHE和酪氨酸酶的中度抑制。然而,其中一些具有相关的抗氧化活性,与研究中使用的标准抗氧化剂相当。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号